Abciximab
Links shared publicly online about this topic
Abciximab disappoints in AMI shock in PRAGUE-7
theheart.org — “Seriously ill patients with acute MI complicated by cardiogenic shock did not benefit from the routine use of abciximab during primary PCI, results of the PRAGUE-7 study show.” View full resource at theheart.org
Most Recently Shared on August 31, 2009 at 4:24 pm By:
heartwire: GP IIb/IIIa inhibitor of no benefit in AMI patients with cardiogenic shock http://bit.ly/1EuajE #ESC09
Early abciximab has benefits in high-risk STEMI patients: study - Cardiology Videos - The Doctor's Channel
thedoctorschannel.com — “Early abciximab has benefits in high-risk STEMI patients: study - Cardiology Videos - The Doctor's Channel” View full resource at thedoctorschannel.com
Most Recently Shared on November 7, 2009 at 9:29 pm By:
Tammi Jacobs Health Professional
Early abciximab has benefits in high-risk STEMI patients: study ... http://bit.ly/1fMJrV
Acute Stent Thrombosis Associated with Heparin-Induced Thrombocytopenia and Abciximab-Induced Profound Thrombocytopenia | Journal of Invasive Cardiology
invasivecardiology.com — “Acute Stent Thrombosis Associated with Heparin-Induced Thrombocytopenia and Abciximab-Induced Profound Thrombocytopenia | Journal of Invasive Cardiology” View full resource at invasivecardiology.com
Most Recently Shared on February 11, 2011 at 2:52 pm By:
Invasive Cardiology Cardiology and Medical Journal
Treatment strategies for concomitant heparin- and abciximab-induced profound thrombocytopenia. http://tinyurl.com/4ubtzgc
ISAR-REACT 4 on bivalirudin; IC vs IV abciximab in AIDA STEMI; vorapaxar in TRACER; ADOPT: apixaban vs enoxaparin; rivaroxaban in ATLAS ACS 2
blogs.theheart.org — “ISAR-REACT 4 on bivalirudin; IC vs IV abciximab in AIDA STEMI; vorapaxar in TRACER; ADOPT: apixaban vs enoxaparin; rivaroxaban in ATLAS ACS 2” View full resource at blogs.theheart.org
Most Recently Shared on November 14, 2011 at 4:33 am By:
Dr Walton-Shirley Internist, Cardiologist, Physician, and Doctor
ISAR-REACT 4 on bivalirudin; IC vs IV abciximab in AIDA STEMI; vorapaxar in TRACER; ADOPT:...: ISAR-REACT 4 on b... http://t.co/NFgpkRaX
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on November 16, 2010 at 1:03 pm By:
CICERO: Mixed results for intracoronary abciximab in STEMI: Intracoronary rather than intravenous administration... http://bit.ly/aKNvCC
American Heart Association: More News, 15-Nov-2010
medicalnewstoday.com — “Abstract 21854 - Direct-to-the-heart platelet inhibitor shows promise for heart attack patientsInjecting a platelet inhibitor directly into the heart through a coronary artery (in” View full resource at medicalnewstoday.com
Most Recently Shared on November 17, 2010 at 12:42 pm By:
American Heart Association: More News, 15-Nov-2010 http://mnt.to/3MFR #blood #hematology
Cardiology Medical News about Coronary Artery Disease
mdlinx.com — “Does Abciximab Promote Coronary Artery Remodeling in Patients With Kawasaki Disease” View full resource at mdlinx.com
Most Recently Shared on May 28, 2010 at 7:51 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Does Abciximab Promote Coronary Artery Remodeling in Patients With Kawasaki Disease: The American J... http://bit.ly/cCLEZy #cardio #mdlinx
Cardiology Medical News about Myocardial Infarction
mdlinx.com — “Comparison by Meta-Analysis of Eptifibatide and Tirofiban to Abciximab in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention” View full resource at mdlinx.com
Most Recently Shared on July 7, 2010 at 3:44 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison by Meta-Analysis of Eptifibatide and Tirofiban to Abciximab in Patients With ST-Elevatio... http://bit.ly/bvj950 #cardio #mdlinx
Internal Medicine Article | Myocardial Infarction
mdlinx.com — “Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration” View full resource at mdlinx.com
Most Recently Shared on November 18, 2010 at 2:46 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myo... http://bit.ly/cLAosj #medicine
Cardiology Article | Myocardial Infarction
mdlinx.com — “Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration” View full resource at mdlinx.com
Most Recently Shared on November 18, 2010 at 8:21 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation M... http://bit.ly/dfyLeY #cardiology
Cardiology Medical News about Acute Coronary Syndrome
mdlinx.com — “Comparison of Catheterization Laboratory Initiated Abciximab and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes” View full resource at mdlinx.com
Most Recently Shared on July 7, 2010 at 8:33 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison of Catheterization Laboratory Initiated Abciximab and Eptifibatide During Percutaneous C... http://bit.ly/aX2x7L #cardio #mdlinx
Cardiology Medical News about Myocardial Infarction
mdlinx.com — “One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial” View full resource at mdlinx.com
Most Recently Shared on July 2, 2010 at 8:56 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 ra... http://bit.ly/991vkh #cardio #mdlinx
Family Medicine Article | Acute Coronary Syndrome
mdlinx.com — “Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Observational Registry Study” View full resource at mdlinx.com
Most Recently Shared on May 7, 2011 at 2:46 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutane... http://bit.ly/lQsMjS #FamPractice
Cardiology Medical News about Myocardial Infarction
mdlinx.com — “Intracoronary Compared to Intravenous Abciximab and High-Dose Bolus Compared to Standard Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Transradial Primary Percutaneous Coronary Intervention” View full resource at mdlinx.com
Most Recently Shared on May 29, 2010 at 2:55 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Intracoronary Compared to Intravenous Abciximab and High-Dose Bolus Compared to Standard Dose in Pa... http://bit.ly/dm2k3j #cardio #mdlinx
Acute Coronary Syndrome on #MDlinx
mdlinx.com — “Acute Coronary Syndrome on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 11, 2010 at 3:10 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Local Delivery Versus Intracoronary Infusion of Abciximab in Patients With Acute Coronary Syndromes: JACC... http://bit.ly/asayze #medicine
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Tammi Jacobs
Competent, fun, well designed diet & workout to allow you control to Empower You. Inspiring Women Entrepreneurs Social Media Fan. Find me: http://bit.ly/Get_Fit
-
Invasive Cardiology
The Journal of Invasive Cardiology is a scientific medical journal serving clinicians who treat cardiovascular disease.
Advertisement
